To improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.
By Aimee Simone, Pharmacy Times Assistant Editor
Advertisement
Articles by By Aimee Simone, Pharmacy Times Assistant Editor
Advertisement
Latest Updated Articles
Specialty Pharmacies May Improve Care for Hemophilia, vWD PatientsPublished: October 29th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
4
Accelerated Approval of Cancer Drugs: Benefit or Burden?
5
